Drug Profile
Besifloxacin - Ajanta Pharma
Alternative Names: BesixLatest Information Update: 14 Feb 2019
Price :
$50
*
At a glance
- Originator Ajanta Pharma
- Class Antibacterials; Antivirals; Azepines; Carboxylic acids; Cyclopropanes; Fluoroquinolones; Small molecules
- Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase IV inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Infectious conjunctivitis
Most Recent Events
- 14 Feb 2019 Chemical structure information added
- 12 Jul 2013 Launched for Infectious conjunctivitis in India (Ophthalmic) prior to July 2013
- 04 Sep 2010 Ajanta Pharma completes a phase III trial in Infectious conjunctivitis in India